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Abstract 
 
A novel ethanol injection method using microengineered nickel membrane was 
employed to produce POPC (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine) and 
Lipoid® E80 liposomes at different production scales. A stirred cell device was used 
to produce 73 ml of the liposomal suspension and the product volume was then 
increased by a factor of 8 at the same transmembrane flux (140 l m2 h1), volume 
ratio of the aqueous to organic phase (4.5) and peak shear stress on the membrane 
surface (2.7 Pa). Two different strategies for shear control on the membrane surface 
have been used in the scaled-up versions of the process: a cross flow recirculation 
of the aqueous phase across the membrane surface and low frequency oscillation of 
the membrane surface (40 Hz) in a direction normal to the flow of the injected 
organic phase. Using the same membrane with a pore size of 5 m and pore 
spacing of 200 m in all devices, the size of the POPC liposomes produced in all 
three membrane systems was highly consistent (80-86 nm) and the coefficient of 
variation ranged between 26 and 36 %. The smallest and most uniform liposomal 
nanoparticles were produced in a novel oscillating membrane system. The mean 
vesicle size increased with increasing the pore size of the membrane and the 
injection time. An increase in the vesicle size over time was caused by deposition of 
newly formed phospholipid fragments onto the surface of the vesicles already formed 
in the suspension and this increase was most pronounced for the cross flow system, 
due to long recirculation time. The final vesicle size in all membrane systems was 
suitable for their use as drug carriers in pharmaceutical formulations.  
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Preparation of Liposomes: A Novel Application of Microengineered 
Membranes – From Laboratory Scale to Large Scale 
 
1. Introduction 
    
Liposomes are versatile drug carrier systems that can be tailor-made to 
accommodate a large variety of drugs for a wide range of therapies. Both lipophilic 
and hydrophilic drugs can be incorporated in liposomes, within the phospholipid 
bilayer and in the aqueous core, respectively [1]. The behaviour of liposomes in vivo 
and in vitro can be controlled by selecting the proper characteristics such as vesicle 
size, number of bilayers, bilayer fluidity, charge and hydrophilicity of the external 
surface, and the type of targeting molecules attached to the bilayer surface [2]. The 
applications of lipid vesicles are determined by their properties, which depend on 
molecular and physicochemical parameters as well as on the method of liposome 
preparation [3]. Therefore, a well-characterized methodology for liposome 
manufacture with validated operating procedures is the main requirement for 
producing liposomal populations with acceptable reproducibility and appropriate for 
the intended use. 
Liposomal preparations can be manufactured using a wide variety of methods such 
as thin film hydration, reversed-phase evaporation, detergent dialysis, and solvent 
injection [4]. The major challenge in liposome production is still large scale 
production. Indeed, most of the described preparation techniques are not suitable for 
scaling up from the laboratory level to the industrial production, due to their 
complexity and a low reproducibility and predictability of the preparations obtained. A 
lack of predictability of product quality may be attributed to empirical methods 
traditionally employed for the design of lipid-based delivery systems [5]. Thus, there 
is a strong need to improve traditional manufacturing techniques, leaving behind 
those poorly characterizable methods, based on small batch sizes. 
The ethanol injection method can be used for liposome production at large scale. In 
this process, an ethanolic solution of the lipid mixture is dispersed into an aqueous 
solution through fast injection. From the manufacturing point of view, this technique 
does fulfil the need for a rapid, simple, easily scalable and safe preparation 
technique. Also, this method does not promote degradation or oxidative alterations 
either in the lipid mixture or in active agents to be encapsulated [6]. 
Membrane dispersion, which is considered as an improvement of the ethanol 
injection technique, is a new method of producing liposomes of predetermined size. 
It involves mixing of two miscible liquids (the organic and aqueous phase) by 
injecting the organic phase through a microporous membrane into the aqueous 
phase. It is similar to membrane emulsification [7, 8], which involves the injection of 
one liquid (the dispersed phase) into another immiscible liquid (the continuous 
phase) through a microporous membrane [9, 10]. Micro-engineered membranes, 
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which have a perfect hexagonal array of uniform pores, allow a much more uniform 
and controllable injection of lipid-containing organic phase into an aqueous phase. 
Thus, their use enables a better control over diffusive mixing at the liquid/membrane 
interface where the lipids self-assemble into vesicles. This may provide fine control 
of liposome size distribution and make easier the extrapolation of the results for an 
industrial large scale production. The shear stress at the membrane surface can be 
controlled by [11]: (i) stirring the continuous phase using a paddle stirrer (Figure 1a); 
(ii) cross flow of the continuous phase along the membrane surface (Figure 1b); (iii) 
vibrating (oscillating) the membrane in the continuous phase (Figure 1c).  
 
Figure 1. 
 
Recent studies [10, 12] were focused on the fabrication of liposomes using Shirasu 
Porous Glass (SPG) membrane. It was found that the vesicle size decreased with a 
decrease in the transmembrane flux and phospholipid concentration in the organic 
phase and with an increase in the aqueous to organic phase ratio and the shear 
stress on the membrane surface. Despite all the information provided in the literature 
regarding the effect of different operating and process conditions on vesicle 
characteristics [13-15], there is a lack of information regarding scale-up of liposomes 
production.  
The aim of this study was to evaluate the scale-up of liposome production by a factor 
of 8 and beyond using novel ethanol injection method with microengineered 
membrane. For a small-scale production, a laboratory stirred cell was used, 
composed of a rotating stirrer above a flat disc membrane. For large scale 
production, two different methods were used: (a) recirculation of the continuous 
phase in cross flow along the membrane surface, and (b) oscillation of the 
membrane surface in a direction normal to the flow of the injected phase.  
  
2. Materials and methods 
2.1 Reagents 
Phospholipids used in this study were POPC (1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphocholine) and Lipoid® E80 (obtained from egg yolk lecithin and containing 
82% of phosphatidyl-choline and 9% of phosphatidyl-ethanolamine), both purchased 
from Lipoïd GmbH (Ludwigshafen, Germany). Cholesterol and phosphotungstic acid 
were supplied by Sigma-Aldrich Chemicals (Saint Quentin Fallavier, France). 95 % 
analytical-grade ethanol was supplied by Fisher Scientific (United Kingdom) and 
used as such, without further purification. Ultra-pure water was obtained from a 
Millipore Synergy® system (Ultrapure Water System, Millipore). 
 
2.2 Membranes 
The membranes used were nickel microengineered membranes containing uniform 
cylindrical pores arranged in a hexagonal array with a diameter of 5 or 20 µm and 
pore spacing of 200 µm. The membranes were fabricated by the UV-LIGA process, 
5 
 
which involves galvanic deposition of nickel onto a template formed by 
photolithography [16]. All membranes were supplied by Micropore Technologies Ltd. 
(Hatton, Derbyshire, United Kingdom).  
 
2.3 Experimental equipment 
Schematic illustration of the equipment used is presented in Figure 2. 
 
Figure 2.  
 
Stirred cell device. A Dispersion Cell was supplied by Micropore Technologies Ltd. 
(Hatton, Derbyshire, UK). This device uses a 24 V DC motor (INSTEK model PR 
3060) to drive a paddle-blade stirrer at an adjustable speed controlled by the applied 
voltage. An effective diameter of the membrane fitted at the bottom of the cell was 
3.3 cm and a membrane area was 8.55 cm2. The organic phase was injected 
through the membrane using a peristaltic pump (Watson Marlow 101U, Cornwall, 
UK).  
Cross flow system. Cross flow module (Micropore Technologies Ltd) was 
composed of 4 separate disk membranes, each with a diameter of 7 mm, so the total 
membrane surface area was 1.54 cm2. The cross flow channel was 20 mm wide and 
1 mm high. A syringe pump (Havard Appartus 11 Plus) was used to inject the 
organic phase through the membranes and a peristaltic pump (Watson Matlow 603s, 
Cornwall, UK) was used to recycle the aqueous phase between the module and an 
aqueous phase tank.  
Oscillating membrane system. This system was also supplied by Micropore 
Technologies Ltd. The membrane was composed of 2 foils rolled in the form of a ring 
with a diameter of 30 mm and a length of 20 mm. The membrane had an area of 
34.1 cm2 and was attached to the injection manifold to which an accelerometer was 
fixed. The accelerometer (PCB Piezotronics model M352C65) was connected to a 
National Instruments Analogue to Digital Converter (N1 Edaq-9172) which was 
interfaced to a LabView executable program running on a computer. The information 
provided by the program from the accelerometer was the frequency and the 
amplitude of the oscillations, the amplitude being determined by the direction of the 
travel and the frequency was deduced from the acceleration measurement. The 
oscillation signal was provided by an audio generator (Rapid Electronics), which fed 
a power amplifier driving the electro-mechanical oscillator on which the inlet manifold 
was mounted. The injection manifold had internal drillings to allow the passage of the 
organic phase by a syringe pump (Harvard Apparatus 11 Plus).   
 
2.4 Experimental procedure and shear stress calculation 
The organic phase was composed of 20 mg ml1 of phospholipids and 5 mg ml1 of 
cholesterol (used as a stabilizer) dissolved in ethanol.  
Stirred cell system. The cell was filled with 60 ml of ultrapure water and 13 ml of 
the organic phase was injected through the membrane at 2 ml min1 to achieve a 
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final volume ratio of the aqueous to organic phase of 4.5. The organic phase flux, J, 
was given by: 
AQJ o /              (1) 
where Qo is the volume flow rate of the organic phase and A is the membrane area. 
The organic phase flux was 140 l m2 h1, calculated from Eq. (1), and the stirrer 
speed was 600 rpm. Previous studies in Dispersion Cell [17, 18] have shown that a 
shear stress is not uniformly distributed over the membrane surface, but varies with 
the radial distance r, according to the equations [19]: 
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where D is the stirrer diameter, T is the internal diameter of the stirred cell, b is the 
blade height, and nb is the number of blades (Figure 2a). The Reynolds number, Re, 
is given by: 
)2/(Re 2 aqaqD             (5) 
where ρaq and ηaq are the density and viscosity of the aqueous phase, respectively, 
and ω is the angular velocity of the stirrer. The boundary layer thickness, δ, is given 
by the Landau-Lifshitz equation [17]: 
)/(  aqaq             (6) 
Since the shear stress at the membrane surface is not constant, it can be argued 
that the appropriate value that should be used in comparative investigations is either 
the average or maximum shear. Because the shear stress at r = rtrans is the highest, 
the pressure above the membrane surface at r = rtrans has a minimum value, leading 
to the maximum transmembrane pressure and thus the maximum flux through the 
membrane. Since the membrane is most productive near the transitional radius, the 
shear stress at r = rtrans (maximum shear stress) will be used as a representative  
value in stirred cell experiments. Using Equation (2) or (3) and (6): 
)/(
825.0
max



aqaq
transaq r
            (7) 
In this study, the maximum shear stress was 4.7 Pa and the transitional radius was 
1.1 cm. A scale-up of stirred cell membrane systems is complicated, because the 
shear stress on the membrane surface is a complex function of the system geometry 
and the shear is non-uniformly distributed over the membrane surface (Figure 1a).   
Cross flow system. 480 ml of the aqueous phase was pumped through the cross-
flow channel and overall 107 ml of the organic phase was injected through the 
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membrane at 36 ml min1 (140 l m2 h1) to achieve an aqueous to organic phase 
volume ratio in the final preparation of 4.5. The shear stress on the membrane 
surface generated by cross flow in rectangular channel geometry is given by: 
)2/(3 2WhQ aqaq                       (8) 
where Qaq is the aqueous phase flow rate, and h and W are the height and width of 
the channel, respectively. In order to keep the same shear stress on the membrane 
surface as in the stirred cell device (4.7 Pa), Qaq was set to 3.7 l min
1.  
Oscillating membrane system. A ring membrane was immersed into a beaker 
containing 480 ml of the aqueous phase. The aqueous phase was then sucked into 
the membrane and injection manifold using a syringe in order to ensure that no air 
bubbles were trapped within the organic phase. When air was completely removed, 
the injection tube was attached to the syringe pump. Then, overall 107 ml of the 
organic phase was injected through the membrane at 8 ml min1 (140 l m2 h1) to 
achieve a final aqueous to organic phase volume ratio of 4.5. Oscillations did not 
start until the organic phase emerged on the membrane surface in order to prevent 
pre-mixing within the membrane. In a stirred cell or cross flow system, the shear 
stress does not vary over time at any location on the membrane surface. For 
oscillating membrane system, the shear stress on the membrane surface is a 
sinusoidal function of time (Figure 1c) and the maximum shear is given by:  
2/32/12/3
max )()2( afaqaq                     
(9)
 
where a and f is the amplitude and frequency of the membrane oscillations. Eq. (9) 
suggests that the same max value can be achieved using many different sets of 
frequency and amplitude values. In membrane emulsification, the mean droplet size 
was found to be a function of the maximum shear stress only and not the frequency 
or amplitude used to achieve it [20]. In this study, the frequency and amplitude were 
adjusted to 40 Hz and 1.2 mm, respectively, to obtain the maximum shear stress on 
the membrane surface which is consistent with the cross flow and stirred system (4.7 
Pa). Equation (9) implies that the oscillating membrane system is easy to scale up, 
because the surface shear does not depend on the membrane geometry or the 
geometry of the vessel, or channel, in which the membrane was fitted. A summary of 
the experimental conditions used in different systems is presented in Table 1. 
Table 1. 
In all systems, formation of vesicles occurred as soon as the organic phase was 
brought into contact with the aqueous phase. The liposomal suspension was 
collected and remaining ethanol was removed by evaporation under reduced 
pressure (Buchi, Flawil, Switzerland). After each experiment, the membrane was 
washed by sonication in ethanol for 1 hour, followed by soaking in a siloxane-based 
wetting agent for 30 min in order to increase the hydrophilicity of the surface.  
 
2.5 Liposomes characterization 
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Size analysis. The particle size distribution was measured by differential centrifugal 
sedimentation using a CPS disc centrifuge, model DC 24000 (CPS instruments, 
Florida, USA). A light beam near the outside edge of the rotating disc passed 
through the centrifuge at some distance below the surface of the liquid phase and 
measured the concentration of particles as they settled. The time required for 
particles to reach the detecting beam depends upon the speed and geometry of the 
centrifuge, the difference in density between the particles and the surrounding liquid, 
and the size of the particles. Thus, when operating conditions were stable, 
sedimentation velocity increased with the particle diameter, so that the time needed 
to reach the detector beam was used to calculate the size of the particles [21, 22]. A 
sucrose gradient (from 18% to 26%) was built and the sample was diluted in a 
sucrose solution (30%) before being injected. Prior to the analysis, the instrument 
was calibrated using an aqueous suspension of polybutadiene particles of a known 
size distribution and a mean size of 402 nm. The mean particle size of liposomes 
was expressed as the number-average mean diameter, dav and the polydispersity 
was expressed as the coefficient of variation, CV = (σ/dav) × 100, where σ is the 
standard deviation of particle diameters in a suspension. The smaller CV values 
indicate the narrower size distribution [23, 24]. All dav and CV values will be 
expressed as the mean ± standard deviation (S.D.). 
Microscopic observation. The morphology of the liposomes was observed by 
transmission electron microscopy (TEM) using a CM 120 microscope (Philips, 
Eindhoven, Netherlands) operating at an accelerating voltage of 80 KV. A drop of the 
liposome dispersion was placed on a holey copper grid. A thin film of the liposome 
dispersion was obtained by removing excess solution using a filter paper. Negative 
staining with 2% (w/w) phosphotungstic acid was directly performed on the deposit 
for 1 min. The excess of phosphotungstic solution was removed with a filter paper 
after which the stained samples were transferred to the TEM for imaging.  
 
3 Results and discussion 
3.1 Effect of the phospholipid type  
The characteristics of Lipoid E 80 and POPC vesicles obtained in stirred cell and 
cross-flow systems using membranes with two different pore sizes are compared in 
Table 2. The POPC liposomes prepared using the pore size of 5 m were smaller 
and more uniform than Lipoid E80 liposomes prepared using the same pore size and 
the difference was more significant for cross-flow system, due to longer fabrication 
times. It should be noted that both Lipoid E 80 and POPC allow the formation of 
liposomes with an acceptable size for their use as drug carriers in pharmaceutical 
formulations. Therefore, both phospholipids can be used for large scale production of 
liposomes in a cross-flow membrane system.  
Table 2. 
 
3.2 Effect of the membrane pore size  
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The effect of membrane pore size on the mean size of vesicles prepared in stirred 
cell and cross flow systems can be seen in Table 2. Clearly, the mean liposome size 
increased with increasing the pore size, and the effect was more pronounced for the 
cross-flow system, due to longer fabrication time. In the cross flow system, new 
phospholipid molecules supplied through the membrane by the organic phase were 
partly deposited on the existing liposomal particles that recirculate through the 
module, and partly form new phospholipid fragments in the aqueous phase. As a 
result, the liposomal particles formed in the cross flow system are larger than those 
formed in the stirred cell, where a secondary particle growth is less pronounced due 
to shorter injection time. The effect of the pore size on the vesicle size can also be 
seen in Figure 3. This figure shows that the mean vesicle size was between 50 and 
100 m when 5-m membrane was used and 150 to 200 m when the membrane 
with a 20 m pore size was used. In membrane emulsification, the particle size was 
found to increase linearly with the pore size [19, 25, 26]. The results show that it is 
feasible to tune the size of liposomal particles by using microengineered membranes 
with different nominal pore sizes, but the effect is limited to a relatively narrow range 
of mean vesicle sizes. 
 
3.3 Variation of vesicle size with time during the scale up 
The samples of liposomal nanosuspension prepared in both the cross flow and 
oscillating system were taken at predetermined time intervals to investigate the 
variation of the vesicle size with time. The aqueous to organic phase ratio, R, during 
the fabrication process was inversely proportional to the process time, t:  
)/(/ tQVVVR oaqoaq                     (10) 
where Vaq is the initial volume of the aqueous phase in the system and Qo is the flow 
rate of the organic phase through the membrane, which was kept constant. Thus, 
higher R values in the samples correspond to shorter processing times. As shown in 
Figure 3, the mean size and CV of vesicles in the liposomal suspension increased 
with time. It can be explained by assuming that the supersaturation in the aqueous 
phase was relieved by a combination of nucleation (formation of phospholipid 
fragments) and particle growth (precipitation of phospholipid fragments onto the 
surface of the vesicles already present in the suspension). Initially, formation of 
phospholipid fragments dominates over precipitation but subsequently, precipitation 
of material onto the existing vesicles becomes increasingly more important, leading 
to a gradual increase in the mean vesicle size. A polydispersity of vesicles in the 
suspension increased as a result of coexistence of small vesicles formed directly 
from phospholipid fragments and larger vesicles formed by precipitation onto the 
smaller vesicles. The large vesicles can also be produced at the higher phospholipid 
concentration in the organic phase, as suggested elsewhere [9, 10, 27, 28].  
 
Figure 3.  
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As shown in Figure 3, in the cross flow system, the mean vesicle size increased over 
time by 80% (from 58 to 108 nm), whereas in the oscillating system the size variation 
over time was only by 8% (from 74 to 80 nm). The model of vesicles formation 
proposed by Lasic [29] suggests that following their injection, phospholipids 
precipitate at the water/ethanol boundary and form bilayered phospholipid fragments. 
The energy needed to curve a flat bilayer fragment into a closed sphere was 
provided here through agitation of the aqueous phase, cross flow or membrane 
vibrations. When cross flow system was used, the recirculation of the formed 
vesicles in a closed loop facilitated their contact with the newly formed small vesicles 
and phospholipid fragments, which might result in the formation of bigger vesicles. A 
contact of phospholipid fragments with existing vesicles was pronounced by a 
narrow cross flow channel with a height of 1 mm and a long recirculation time.  
The results in Figure 3 indicate that the vesicle size can be precisely controlled by 
monitoring the processing time, thereby controlling the amount of organic phase 
injected through the membrane. This finding is highly relevant since it can enable 
continuous production of liposomes with different mean particle sizes using a single 
pore size. It is important to note that both cross flow and oscillating membrane 
systems are scalable and the fabrication process developed in a small device can be 
carried out under the same shear conditions in a cross flow or oscillating system with 
a much larger membrane area. On the other hand, a stirred system is not scalable 
due to large spatial variations of the shear stress over the membrane surface (Fig. 
1a) and a significant effect of the system geometry on the shear stress.  
 
3.4 Comparison of different fabrication methods 
 
Once optimized at small scale (Vaq = 60 ml) in stirred cell, the fabrication of POPC 
liposomes was scaled up by a factor of 8 (Vaq = 480 ml) at constant R, J, and max. 
The larger vesicle size and broader particle size distribution was obtained in the 
cross flow system, compared to that in the stirred cell (Table 3). The scale-up was 
done by maintaining constant Vaq/Vo and J values and thus, the fabrication time, t, 
should be proportional to Vaq/A. In the cross-flow system, the membrane area A was 
5.6 times smaller than that in the stirred cell and thus, for an eightfold increase in the 
aqueous phase volume, the process time in the cross-flow device should be 48 times 
longer than that in the stirred cell (Table 3). The recirculation of the liposomal 
suspension over a time period of 297 min led to an increase in the mean vesicle size 
since the newly formed bilayered fragments settle upon the already formed vesicles. 
This can explain why the mean vesicle size was increased from 81 to 86 nm when 
the cross flow system was used, instead of the stirred cell.   
Table 3 
 
The membrane oscillation was used as an alternative to cross flow in order to avoid 
the requirement for recirculation of the organic phase along the membrane surface. 
The shear stress on the membrane surface is a sinusoidal function of time (Fig. 1c), 
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but at 40 Hz, there were 80 peak shear events per second (one peak shear event 
every 12.5 ms). The organic phase was split into more than 90 thousand streams 
within the membrane, before being mixed with an aqueous phase on the other side 
of the membrane. The average flow velocity of the organic phase in the pores was 7 
cm s1 and the distance travelled by each stream between two peak shear events 
was less than 0.9 mm. The mean vesicle size in the oscillating system was the same 
as that in the stirred cell and the CV improved from 29% to 26% (Table 3). Holdich et 
al. [20] attributed the better uniformity of the particles produced by the oscillating 
system to the fact that in such a system the shear stress is only applied at the 
membrane surface (where it is needed), while it is very low in the bulk of the 
aqueous phase. In addition, shear conditions on the membrane surface can be more 
finely adjusted by varying two parameters, the frequency and the amplitude of 
membrane oscillations. In the stirred cell, the shear can only be controlled by varying 
the stirrer speed. Zhu and Barrow [30] reported that the use of a vibrating membrane 
had a significant effect in reducing the size of the droplets generated in membrane 
emulsification.  
The process capacity, defined as the volume of the liposomal suspension produced 
per unit time, was the maximum for the oscillating system (Table 3). The scale-up 
was done at constant flux and Vaq/Vo and thus, the process capacity was 
proportional to A/Vaq and inversely proportional to the process time. The fabrication 
time in the oscillating system was about 23 times shorter than that in the cross-flow 
system resulting in the higher capacity of the oscillating system by a factor of 23.    
Table 4 summarises potential advantages and disadvantages of the various 
membrane systems used for liposomes preparation. An advantage of cross-flow and 
oscillating system is that the volume of the aqueous phase is decoupled from the 
membrane area. In a stirred cell, the aqueous phase volume is limited by the 
membrane area, because D/H should be within certain limits to achieve a 
satisfactory mixing rate. Another advantage of cross-flow and oscillating membrane 
systems over batch stirred cells is that cross-flow and oscillating systems can be 
operated continuously or semi-continuously and a total membrane area in these 
systems can easily be increased by adding additional membrane elements and 
assemblies.  
Table 4. 
 
3.5  TEM observation 
Liposomes prepared with different techniques were observed by Transmission 
Electron Microscopy (TEM) and TEM micrographs are given in Figure 4. 
 
Figure 4.  
 
As could be seen, liposomes were spherical with multilayered membrane structure 
specific to multilamellar vesicles. Their size estimated from TEM pictures ranged 
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from 60 to 120 nm which is coherent with the values obtained using the CPS 
instrument.  
 
4 Conclusion  
Multilamellar phospholipid vesicles were produced by injection of ethanolic phase 
through a microengineered membrane into aqueous phase using different 
membrane devices and batch sizes. The process developed in a stirred cell device 
was scaled-up by a factor of 8 by maintaining the same transmembrane flux, peak 
shear stress on the membrane surface and aqueous to organic phase phase ratio. In 
the cross flow system, the vesicle size increased over time due to continual 
recirculation of the liposomal suspension. The oscillating membrane system, which 
avoids recirculation of the liposomes was fully capable of maintaining the size and 
polydispersity of the liposomal nanoparticles during scale-up. This technique can 
easily be further scaled up by providing a larger membrane area in the oscillating 
membrane assembly. By an appropriate manipulation of hydrodynamic conditions 
during the process scaling up, it is possible to obtain small liposomes with a narrow 
size distribution. These results show great potential of microengineered membranes 
with constant pore spacing to be used for design, rationalization and intensification of 
industrial production of liposomes.  
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Table 1. 
 
Experimental conditions used in different preparation methods. The aqueous to organic phase ratio, transmembrane flux and shear 
stress on the membrane surface were held constant to conduct experiments under comparable conditions.  
 
Preparation method 
Stirred cell 
system 
Cross flow 
system 
Oscillating 
membrane system 
Aqueous phase volume (ml) 60 480 480 
Organic phase volume (ml) 13 107 107 
Final aqueous to organic phase volume ratio (-) 4.5 4.5 4.5 
Organic phase flow rate (ml min1) 2 0.36 8 
Membrane area (cm2) 8.55 1.54 34.1 
Transmembrane flux (l m2 h1) 140 140 140 
Agitation speed (rpm) 600 N.A N.A 
Aqueous phase flow rate (l min1) N.A 3.7 N.A 
Maximum shear stress on membrane surface (Pa) 4.7 4.7 4.7 
 
Table 1
Table 2. 
Influence of phospholipid type and membrane pore size on the mean vesicle size and 
CV in stirred cell and cross flow systems. The experimental conditions are specified 
in Table 1. 
Preparation 
method 
Phospholipid 
used 
Membrane pore 
size (µm) 
Liposomes mean 
size* (nm) 
CV* (%) 
Stirred cell 
system 
Lipoid E 80 
5 87 ± 3 32 ± 1 
20 91 ± 3 34 ± 1 
POPC 5 81 ± 3 29 ± 1 
Cross flow 
system 
Lipoid E 80 
5 105 ± 3 46 ± 1 
20 204 ± 2 45 ± 2 
POPC 5 86 ± 2 36 ± 2 
 
*: Each value represents the mean ± S.D. (n=3) 
 
Table 2
Table 3.  
Comparison of different methods of liposome preparation. The phospholipid: POPC, 
final aqueous to organic phase volume ratio: 4.5, membrane pore size: 5 µm. The 
other experimental conditions are specified in Table 1. 
Preparation 
method 
Mean vesicle 
size*, nm 
CV*, 
% 
Suspension 
volume, ml 
Process 
time, min 
Process 
capacity, 
ml min1 
Stirred cell 81 ± 3 29 ± 1 73 6.5 11 
Cross flow 86 ± 2 36 ± 2 587 297 2 
Oscillating 
system 
80 ± 2 26 ± 1 587 13 45 
 
*: Each value represents the mean ± S.D. (n=3) 
Table 3
Table 4.  
Comparison of different membrane systems used in this work for fabrication of liposomes. 
Preparation 
method 
Potential advantages Potential disadvantages 
Stirred cell system 
- Laboratory test system, easy to use in order to 
study the effect of different experimental conditions 
on the preparation characteristics. 
- High injection rates of the dispersed phase through 
the membrane. 
- Suitable for low volumes of aqueous phase. 
- Suitable only for small scale production (the batch 
volume was limited to 120 ml).  
- Suitable only for batch-wise operation. 
- A non-uniform shear stress at the membrane surface, 
which depends on the cell geometry.  
Cross flow system 
- Constant shear stress at the membrane surface. 
- Modules widely available and easy to use.  
- Suitable for large scale production and continuous 
or semi-continuous operation. 
 
- Liposomal particles can be damaged during 
recirculation in pipes and pump. 
- Not suitable for low volumes of aqueous phase (at 
least 400 ml of the aqueous phase is needed for the 
circulation in pipes and pumps). 
Oscillating 
membrane 
system 
 
- Uniform spatial distribution of shear stress on the 
membrane surface. 
- Suitable for fragile and structured particles. 
- Suitable for low volumes of aqueous phase. 
- Suitable for large scale and continuous operation. 
- Complicated and more expensive design. 
- Higher power consumption. 
- Non-uniform temporal distribution of shear stress on 
the membrane surface. 
 
 
Table 4
Figure Captions 
 
Figure 1. Generation of shear stress in membrane microfluidic processes and its 
spatial or temporal distribution over the membrane surface: (a) Paddle stirrer; (b) 
continuous phase cross flow; (c) oscillating membrane. All three methods of shear 
generation were used in this work to enhance the mixing rate of the two phases.  
 
Figure 2. Schematic illustration of the different equipments used in this study: (A) 
Stirred cell with a simple paddle stirrer above a flat disc membrane (b = 12 mm, D = 
32 mm, Dm = 33 mm, nb = 2 and T = 40 mm); (B) Cross flow system; (C) Oscillating 
membrane system. 
 
Figure 3. The variation of the mean vesicle size, dav and its coefficient of variation, 
CV with the final aqueous to organic phase volume ratio: () Lipoid E 80, cross flow, 
dp = 5 m; () POPC, oscillating system, dp = 5 m; () Lipoid E 80, cross flow, dp = 
20 m. max = 4.7 Pa, J = 142 l m
2 h1. The each data point represents the mean ± 
S.D. (n=3). 
 
Figure 4. Transmission electron microscopy of liposomes prepared with (A) stirred 
cell device (B) cross flow system and  (C) oscillating membrane system. 
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